Acadia Healthcare Company, Inc. (ACHC)
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
- Ticker
- ACHC
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Market cap
- $3.36B
- 52-week range
- $11.43 - $39.38
Valuation
- Share price
- $37.00 (close of Nov 6, 2026)
- P/E (TTM)
- -2.98x
- Price to book
- 1.66x
- Price to free cash flow
- -140.97x
- Enterprise value
- $5.71B
- Book value per share
- $22.25
Price performance
| Period | Change |
|---|---|
| 1 day | +6.35% |
| 5 days | +23.50% |
| 1 month | +27.41% |
| 3 months | +20.44% |
| 6 months | +46.25% |
| Year to date | +160.75% |
| 1 year | +82.63% |
| 3 years | -49.67% |
| 5 years | -42.39% |
| 10 years | -0.86% |
| All time | +54.17% |
Short interest
- As of
- Oct 15, 2026
- Short % of float
- 35.84%
- Shares short
- 20.94M
- Days to cover
- 13.70
- Change since prior report
- -8.04%
- Source
- FINRA consolidated short interest
Profitability and growth
- Return on equity
- -56.58%
- Return on invested capital
- -20.18%*
- Return on assets
- -19.95%
- Return on capital employed
- -18.53%*
- Net margin
- -33.29%
- EBITDA margin
- -22.60%
- Revenue growth
- 5.04%
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash flow and balance sheet
- Free cash flow yield (TTM)
- -0.71%
- Current ratio
- 1.60x
- Net debt to EBITDA
- -3.22x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Revenue
- $3.31B
- EBITDA
- -$748.68M
- Net income
- -$1.10B
- Earnings per share
- $-12.16
- Interest expense
- $138.86M
- Shares outstanding
- 90.70M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | $3.31B | - | -$1.10B | -$12.16 |
| 2024-12-31 | $3.15B | - | $255.61M | $2.79 |
| 2023-12-31 | $2.93B | - | -$21.67M | -$0.24 |
| 2022-12-31 | $2.61B | - | $273.14M | $3.05 |
| 2021-12-31 | $2.31B | - | $190.63M | $2.15 |
| 2020-12-31 | $2.09B | - | -$672.13M | -$7.65 |
| 2019-12-31 | $2.01B | $676.28M | $108.92M | $1.24 |
| 2018-12-31 | $1.90B | $680.18M | -$175.75M | -$2.01 |
| 2017-12-31 | $2.84B | $680.76M | $199.84M | $2.30 |
| 2016-12-31 | $2.81B | $695.39M | $6.14M | $0.07 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | - | -33.29% | -56.58% | -20.18%* |
| 2024-12-31 | - | 8.10% | 8.32% | 7.38%* |
| 2023-12-31 | - | -0.74% | -0.78% | 1.33%* |
| 2022-12-31 | - | 10.46% | 9.71% | 8.06%* |
| 2021-12-31 | - | 8.24% | 7.57% | 6.84%* |
| 2020-12-31 | - | -32.16% | -35.39% | 5.83%* |
| 2019-12-31 | 33.67% | 5.42% | 4.35% | 9.66% |
| 2018-12-31 | 35.71% | -9.23% | -7.53% | 10.56% |
| 2017-12-31 | 24.00% | 7.05% | 7.77% | 9.76% |
| 2016-12-31 | 24.74% | 0.22% | 0.28% | 10.63% |
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $133.24M | $2.47B |
| 2024-12-31 | $76.31M | $1.88B |
| 2023-12-31 | $100.07M | $1.34B |
| 2022-12-31 | $97.65M | $1.36B |
| 2021-12-31 | $133.81M | $1.48B |
| 2020-12-31 | $378.70M | $2.97B |
| 2019-12-31 | $99.53M | $3.11B |
| 2018-12-31 | $50.51M | $3.16B |
| 2017-12-31 | $67.29M | $3.21B |
| 2016-12-31 | $57.06M | $3.25B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | -$439.91M | $31.71M |
| 2024-12-31 | -$560.69M | $37.11M |
| 2023-12-31 | $38.21M | $32.29M |
| 2022-12-31 | $84.42M | $29.64M |
| 2021-12-31 | $129.67M | $37.53M |
| 2020-12-31 | $433.84M | $22.50M |
| 2019-12-31 | $100.22M | $17.31M |
| 2018-12-31 | $160.89M | $22.00M |
| 2017-12-31 | $125.40M | $23.47M |
| 2016-12-31 | $54.01M | $28.34M |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-11-04 | Sep 2026 | $0.46 |
| 2026-07-28 | Jun 2026 | $0.33 |
| 2026-04-29 | Mar 2026 | $0.28 |
| 2026-02-25 | Dec 2025 | $0.03 |
| 2025-11-05 | Sep 2025 | $0.67 |
| 2025-08-05 | Jun 2025 | $0.71 |
| 2025-05-12 | Mar 2025 | $0.35 |
| 2025-02-27 | Dec 2024 | $0.72 |
Filings and sources
- Company website
- acadiahealthcare.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades